Sponsors
10 2-hour sessions including: 16 Lectures and Panels 8 Dinner Guests Innovation Day / Reception 10 Dinners (Café Luna)
Hypothesize Observe Publish IP LawFinancing Market Sizing
Learning Objectives Matching technologies to unmet clinical needs Quantitative evaluation of market potential Develop IP strategy Articulation of the go-to-market strategy Fundamentals of the VC pitch Management of a fledgling medtech company
DateTimeTopicsLocation Sept 84:30-5:20 pmArrivalAmphitheater 5:30-6:20 pmCourse Overview/Sample Pitch PresentationAmphitheater Sept 154:30-5:20 pmIntroductory LectureAmphitheater 5:30-6:20 pmKeynote LectureAmphitheater Sept 224:30-5:20 pmHow to Make It As First-Time CEOAmphitheater 5:30-6:20 pmRegulatory Considerations in PharmaAmphitheater Sept 294:30-5:20 pmInventors’ PresentationsAmphitheater 5:30-6:20 pmReimbursmentAmphitheater Oct 64:30-5:20 pmWhere Do You Find Money?Amphitheater 5:30-6:20 pmAngel InvestorsAmphitheater Oct 134:30-5:20 pmIP LawAmphitheater 5:30-6:20 pmMarket Analysis IAmphitheater Oct 204:30-5:20 pmRegulatory Considerations for DevicesAmphitheater 5:30-6:20 pmMarket Analysis IIAmphitheater Oct 274:30-5:20 pmCase Studies IAmphitheater 5:30-6:20 pmCase Studies IIAmphitheater Nov 34:30-5:20 pmResources IAmphitheater 5:30-6:20 pmResources IIAmphitheater Nov 104:30-5:20 pm Innovation Day/ Pitch Competition Amphitheater 5:30-6:20 pm Innovation Day/ Pitch Competition Amphitheater
Innovation Day / Team Work Approximately 5 patents/ideas will be presented Sep 29 Teams of 4-6 people will be formed based on preferences Teams will work on a business plan Business plans will be presented Nov 10 to live judges Presentations will be exactly 10 minutes, ~ 10 slides
Expectations Attendance at keynote lecture (Sep 15) Attendance and participation at innovation day (Nov 10) Maximum of 2 missed classes (not including above) Active team participation Failure to meet the above criteria will result in loss of $100 deposit
@HarvardHIC2015 Web:
Christoph Westphal M.D., Ph.D. Partner, Longwood Fund Founder: Sirtris, Alnylam, Momenta, Acceleron, Alnara, OvaScience, FlexPharma, Verastem Keynote Address
Partner, Siemens Venture Capital Founder, Startup Leadership Program HIC Founder Investor: Biolmagene China Diagnostics Cylex Sequenom (NASD: SQNM) Anupendra Sharma, M.B.A. Keynote Address
Speakers - Day 3 Sameer Sabir, MBA CEO, MoMelan Technologies “How to Make it as First-Time CEO” Pravin Chaturvedi CEO, IndUS Pharmaceuticals Serial entrepreneur, 25+ years drug development experience “Regulatory Considerations in Pharma”
VP, Stemnion, Inc. 30+ years of experience in business strategy, product commercialization, R&D planning and business development in the biotech, pharmaceutical and medical products industries Skip Irving, M.B.A. Reimbursement
Speakers - Day 5 Aaron Sandoski, MBA Co-founder and Managing Director, Norwich Ventures “Where Do You Find Money?” Richard Anders, JD Founder and Managing Director, Massachusetts Medical Angels Lecturer, Harvard & MIT. “Dynamics of the Biomedical Enterprise”, “Evaluating a Biomedical Business Concept” “Angel Investment”
Speakers - Day 6 Domenick Bertelli, MBA, and Matthew Riordan, MBA Partners, Putnam Associates Strategy consulting, US and Global Pharmaceutical, Biotech & Medical Device industries HIC sponsors “Market analysis”
Speakers - Day 7 Nandini Murthy, MS Principal, ENEM Consulting over 18 years of experience in regulatory affairs, clinical and quality assurance “Regulatory Considerations for Medical Devices ” John Fletcher, MBA, Guy Fish, MD, MBA Fletcher Spaght Inc – strategy consulting; Fletcher Spaght Ventures - venture capital fund “Market Analysis”
Speakers - Day 8 (Case Studies) Armon Sharei, PhD. CEO, SQZ Biotech Ailis Tweed-Kent, MD. CEO, Cocoon Biotech Fiorenzo Omenetto, PhD, Michael Shrader, MBA, Aaron Sandoski, MBA. Co-founders, Vaxess
Speakers - Day 9 (Resources) Johannes Fruehauf, PhD Alice Ly, PhD Abi Barrow, PhD Curtis Keith, PhD
Dinner Guests PhDs/ MDs who have recently transitioned from academia to industry Brief introduction to current position/ area and the transition Talk after last lecture of the day, Q&A at dinner Fields: Business Development, Venture Capital, Consulting, Medical Affairs, Research and Development